FRESENIUS Kabi USA has issued a voluntary recall of Midazolam Injection, USP, 2 mg/2 mL in prefilled single-use glass syringes.
The blister packaging contains syringes containing and labeled as ondansetron injection, 4 mg/2 mL, an anti-emetic branded Zofran.
The recall announcement said missing a dose of midazolam could lead to ineffective sedation and no reduction in anxiety, according to the Food and Drug Administration.
The company said it had not received any reports of adverse events related to the recall.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Nov 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Nov 17
